Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health

16 June 2017

Biosimilar medicines are transforming treatment by enabling better access to […]

Over 100 Participants Explore Opportunities to Ensure Universal Access to Health

27 April 2017

Over 100 participants explored different ways and opportunities to ensure […]

22^nd EAHP Conference in Cannes

25 March 2017

A special satellite  symposium was organized on “Value added medicines […]

Access to Medicines at Sustainable Price: Pharma Industry and Governments Transforming Challenges into Opportunities

23 March 2017

Stimulating Investment in European Generic, Biosimilar and Value Added Medicines through a Transparent Legal Environment

22 March 2017

Key authorities, eminent lawyers and industry leaders discussed today in […]

European Parliament Recognises the Major role of Generic, Biosimilar and Value Added Medicines in Improving Access

2 March 2017

Today, the European Parliament voted on the report on ‘Options […]

Joint Declaration for an ambitious EU industrial strategy

27 February 2017

Europe is the cradle of the manufacturing industry and has […]

Joint statement on Shortages

2 February 2017

The European associations representing manufacturers of medicinal products, parallel distributors, […]

European Parliament prioritises Generic, Biosimilar and Value Added Medicines Competition to improve Access

31 January 2017

Today, the Environment, Public Health and Food Safety Committee (ENVI) voted […]

Building a 21^st Century Regulatory Environment for Better Patient Access to Medicines

26 January 2017

This week in London, Medicines for Europe gathers national authorities, […]